Sessa Capital (Master), L.P. Provention Bio, Inc. (PRVB) insider trading activity

Sessa Capital (Master), L.P. is > 10% Shareholder of Provention Bio, Inc.. Currently has a direct ownership of 0 shares of PRVB, which is worth approximately $0. The most recent transaction as insider was on Apr 27, 2023, when has been sold 15,567,497 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Sessa Capital (Master), L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 27 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	15,567,497 Reduced 100.0%	0 Common Stock
Apr 21 2023	SELL Bona fide gift	-	224,617 Reduced 100.0%	0 Common Stock
Apr 20 2023	SELL Bona fide gift	-	202,314 Reduced 47.39%	224,617 Common Stock
Apr 14 2023	SELL Open market or private sale	$53,274,151 $24.32 p/Share	2,190,549 Reduced 12.34%	15,567,497 Common Stock
Apr 14 2023	BUY Exercise of in-the-money or at-the-money derivatives securities	$53,274,138 $6.0 p/Share	8,879,023 Added 33.33%	17,758,046 Common Stock
Apr 04 2023	SELL Bona fide gift	-	218,651 Reduced 33.87%	426,931 Common Stock
Mar 31 2023	SELL Other acquisition or disposition	-	3,000,000 Reduced 25.25%	8,879,023 Common Stock
Jan 18 2023	SELL Open market or private sale	$28,200,000 $9.4 p/Share	3,000,000 Reduced 20.16%	11,879,023 Common Stock

Also insider at

SABS

SAB Biotherapeutics, Inc. Healthcare

Director

SC(